- Home
- LIF vs LEGN Comparison
LIF vs LEGN Comparison
Compare LIF & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIF
- LEGN
- Stock Information
- Founded
- LIF 2008
- LEGN 2014
- Country
- LIF United States
- LEGN United States
- Employees
- LIF N/A
- LEGN N/A
- Industry
- LIF
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- LIF
- LEGN Health Care
- Exchange
- LIF Nasdaq
- LEGN Nasdaq
- Market Cap
- LIF 4.8B
- LEGN 5.4B
- IPO Year
- LIF N/A
- LEGN 2020
- Fundamental
- Price
- LIF $74.38
- LEGN $41.59
- Analyst Decision
- LIF Strong Buy
- LEGN Strong Buy
- Analyst Count
- LIF 6
- LEGN 11
- Target Price
- LIF $59.50
- LEGN $74.60
- AVG Volume (30 Days)
- LIF 789.3K
- LEGN 1.6M
- Earning Date
- LIF 08-11-2025
- LEGN 08-08-2025
- Dividend Yield
- LIF N/A
- LEGN N/A
- EPS Growth
- LIF N/A
- LEGN N/A
- EPS
- LIF 0.04
- LEGN N/A
- Revenue
- LIF $396,881,000.00
- LEGN $728,303,000.00
- Revenue This Year
- LIF $27.69
- LEGN $65.33
- Revenue Next Year
- LIF $22.16
- LEGN $54.68
- P/E Ratio
- LIF $1,789.21
- LEGN N/A
- Revenue Growth
- LIF 26.15
- LEGN 112.46
- 52 Week Low
- LIF $28.94
- LEGN $27.34
- 52 Week High
- LIF $74.91
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- LIF N/A
- LEGN 71.42
- Support Level
- LIF N/A
- LEGN $38.53
- Resistance Level
- LIF N/A
- LEGN $40.78
- Average True Range (ATR)
- LIF 0.00
- LEGN 1.72
- MACD
- LIF 0.00
- LEGN 0.39
- Stochastic Oscillator
- LIF 0.00
- LEGN 76.29
About LIF Life360 Inc. Common Stock
Life360 is the world's largest family-focused social network, with over 50 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.